Towa Pharmaceutical

Towa is a pharmaceutical company specialized in generics. Founded Osaka in 1951, for over 70 years we have been dedicated to the research and development, production, and marketing of these products in Japan. Towa is listed on the Tokyo Stock Exchange and is one of Japan’s three leading companies in its sector. Our corporate purpose is to contribute to people’s health. Each of our employees looks carefully at how patients think and feel to inspire their daily work. In the current super-aged society, we make continuous efforts for stable supplies of generics that can help reduce users’ medical payments and counter increasing social security and medical costs while maintaining the quality of medical services. We are also embarking on new business areas that will help improve people’s health and life expectancy. In addition to promoting stable supply, quality assurance, and information provision about generics, we focus on research and development of innovative initiatives to make our products easier to take and handle. To enter new markets, we also promote the construction of a structure that can provide Towa group’s added-value formulations to patients around the world through our overseas companies. Not limiting ourselves to current drug treatments, we will create health-related businesses compatible with emerging medical systems by utilizing our existing knowledge and skills, acquiring new technologies and combining them all together. We will make further efforts to be a company heartily appreciated by society and local communities at all times.